Barclays PLC Definitive Healthcare Corp. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Definitive Healthcare Corp. stock. As of the latest transaction made, Barclays PLC holds 91,312 shares of DH stock, worth $294,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,312

Previous 81,916 11.47%

Holding current value

$294,937

Previous $366,000 2.73%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$4.08 - $4.77 $38,335 - $44,818	9,396 Added 11.47%	91,312 $376,000
Q3 2024 Nov 15, 2024	BUY	$3.55 - $6.03 $221,356 - $375,994	62,354 Added 318.75%	81,916 $366,000
Q2 2024 Aug 14, 2024	SELL	$5.15 - $8.02 $124,939 - $194,565	-24,260 Reduced 55.36%	19,562 $106,000
Q1 2024 May 15, 2024	SELL	$7.61 - $10.26 $227,736 - $307,040	-29,926 Reduced 40.58%	43,822 $353,000
Q4 2023 Feb 15, 2024	BUY	$5.7 - $10.21 $330,389 - $591,802	57,963 Added 367.2%	73,748 $733,000
Q3 2023 Nov 07, 2023	SELL	$7.77 - $12.12 $7,296 - $11,380	-939 Reduced 5.61%	15,785 $127,000
Q2 2023 Aug 03, 2023	SELL	$9.0 - $11.86 $286,020 - $376,910	-31,780 Reduced 65.52%	16,724 $183,000
Q1 2023 May 04, 2023	BUY	$9.72 - $14.01 $452,514 - $652,235	46,555 Added 2388.66%	48,504 $502,000
Q4 2022 Feb 13, 2023	SELL	$10.14 - $17.01 $3,224 - $5,409	-318 Reduced 14.03%	1,949 $21,000
Q3 2022 Nov 03, 2022	SELL	$15.54 - $29.33 $13,581 - $25,634	-874 Reduced 27.83%	2,267 $35,000
Q2 2022 Aug 12, 2022	BUY	$15.42 - $26.15 $43,314 - $73,455	2,809 Added 846.08%	3,141 $72,000
Q1 2022 May 16, 2022	BUY	$18.52 - $28.15 $6,148 - $9,345	332 New	332 $8,000

Others Institutions Holding DH

# of Institutions

134

Shares Held

107M

Call Options Held

2.3K

Put Options Held

4.2K

View Full List

About Definitive Healthcare Corp.

Ticker DH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 100,511,000
Market Cap $325M
Description
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's...

More about DH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account